Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 3Y Ago
-0.8x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -22.41% |
| Q3 2025 | -17.84% |
| Q2 2025 | 1.05% |
| Q1 2025 | -15.01% |
| Q4 2024 | -17.44% |
| Q3 2024 | 37.46% |
| Q2 2024 | 27.70% |
| Q1 2024 | 29.85% |
| Q4 2023 | 5.27% |
| Q3 2023 | 89.32% |
| Q2 2023 | -3.33% |
| Q1 2023 | 57.24% |
| Q4 2022 | 29.03% |
| Q3 2022 | 8.29% |
| Q2 2022 | -17.45% |
| Q1 2022 | 2.45% |
| Q4 2021 | 0.00% |